Regulation of connective tissue synthesis in systemic sclerosis

Area of Science:

• Rheumatology
• Dermatology
• Cell Biology

Background:

• Systemic sclerosis (SSc) is characterized by excessive connective tissue deposition, primarily fibrosis, causing significant morbidity.
• Unregulated collagen production by skin fibroblasts is a critical factor in SSc pathogenesis.
• Overexpression of extracellular matrix components and upregulated gene transcription are observed in SSc fibroblasts.

Purpose of the Study:

• To investigate the mechanisms underlying fibroblast activation and extracellular matrix deposition in systemic sclerosis.
• To elucidate the role of transforming growth factor-beta (TGF-β) in SSc-associated fibrosis.
• To understand the persistence of elevated extracellular matrix gene expression in SSc.

Main Methods:

• In vivo and in vitro studies of SSc skin fibroblasts.
• Analysis of gene transcriptional activity for matrix macromolecules.
• Assessment of transforming growth factor-beta (TGF-β) expression in affected tissues.
• Evaluation of fibroblast collagen synthesis in three-dimensional matrices.

Main Results:

• SSc fibroblasts exhibit unregulated collagen production.
• Transforming growth factor-beta (TGF-β) is highly expressed in SSc tissues, particularly around blood vessels and inflammatory cells.
• SSc fibroblasts demonstrate a failure to down-regulate collagen synthesis in a three-dimensional matrix.
• Subpopulations of activated fibroblasts may dominate in SSc.

Conclusions:

• Fibrosis in SSc results from complex interactions, including genetic and hormonal factors, leading to persistent elevation of extracellular matrix gene expression.
• Transforming growth factor-beta (TGF-β) is a key mediator in initiating and perpetuating the fibrotic response in SSc.
• Understanding fibroblast activation mechanisms is crucial for developing targeted therapies for SSc.